Dr. Robert Galvin is the Chief Executive Officer of Equity Healthcare (EH) at the Blackstone Group, which oversees the management of health care for firms owned by private equity companies. EH’s focus is on using purchasing power to create innovative ways to achieve higher value health care through improved population health, clinical quality, and delivery system reforms. Currently, EH encompasses 45 companies with health care spending exceeding $1.5 billion annually. It is a wholly owned subsidiary of the Blackstone Group, where Dr. Galvin is an Operating Partner. Previously, Dr. Galvin was Executive Director of Health Services and Chief Medical Officer for General Electric (GE) for 15 years, where he was in charge of the design and financial and clinical performance of GE’s health programs globally. He was also responsible for health policy strategies affecting employees. Dr. Galvin is a nationally recognized leader in the areas of market-based health policy and financing, quality measurement, and payment reform. His work has been widely published in the Harvard Business Review, New England Journal of Medicine, JAMA, and Health Affairs. Dr. Galvin was a co-founder of the Leapfrog Group and founder of two other groups, Bridges to Excellence/PROMETHEUS Payment and Catalyst for Payment Reform (CPR), all innovative endeavors that have helped drive the quality agenda. Dr. Galvin is a member of the Institute of Medicine (IOM), a branch of the National Academy of Sciences, and sits on the IOM’s board on health care services. He is also on the boards of the National Quality Forum and CPR. Dr. Galvin is Professor Adjunct of Medicine and Health Policy at Yale University. He has received awards for his work from National Business Group on Health, Healthcare Financial Management Association, and National Coalition for Cancer Survivorship. He is a fellow of the American College of Physicians.